The era of the all-powerful CEO is over. Today’s chief executives face a complex web of board dynamics, activist shareholders, and stakeholder pressures that require diplomatic skills over decisive authority. Success now depends on building consensus rather than commanding obedience.
Leadership Shakeup Reflects Deeper Strategic Divisions Novo Nordisk, the Danish pharmaceutical giant behind blockbuster drugs Ozempic and Wegovy, is experiencing…
A New Era in Diabetes and Cardiovascular Care The landscape of diabetes management has shifted significantly with the FDA’s expanded…
The Generics Mindset: Patent Destruction as Business Strategy In the pharmaceutical world, the divide between innovative drug discovery and generic…
